- €394.91m
- €419.53m
- €69.40m
- 59
- 10
- 86
- 50
R2019 December 31st | R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 35.4 | 37.6 | 50.2 | 60.3 | 69.4 |
Cost of Revenue | |||||
Gross Profit | 9.13 | 11.3 | 13.6 | 15.6 | 21.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 36.3 | 37.5 | 55.6 | 63.4 | 74.6 |
Operating Profit | -0.909 | 0.163 | -5.4 | -3.14 | -5.17 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.08 | -0.233 | -6.86 | -4.92 | -7.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.69 | -0.832 | -6.63 | -2.87 | -5.66 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1.57 | -0.866 | -6.63 | -3.33 | -6.05 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.57 | -0.866 | -6.63 | -3.33 | -6.05 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.273 | -0.047 | -0.749 | -0.295 | -0.194 |
Dividends per Share |